Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity

European Journal of Pharmacology

Volumn 57, Issue 2-3, 1979, Pages 201-210

  Porsolt, Roger D ^a   Bertin, Anne ^a   Blavet, Nadine ^a   Deniel, Martine ^a   Jalfre, Maurice ^a  

^a Centre de Recherche Delalande   (France)

Author keywords

Dopamine; Noradrenaline; Screening model for antidepressants; Serotonin Biochemical correlates

Indexed keywords

2 ETHYL 1,2,3,4,6,7 HEXAHYDRO 2 HYDROXY 3 ISOBUTYL 9,10 DIMETHOXY 11BH BENZO[A]QUINOLIZINE; ALPHA ADRENERGIC RECEPTOR; ANTIDEPRESSANT AGENT; APOMORPHINE; BROMOCRIPTINE; CITALOPRAM; CLOMIPRAMINE; CLONIDINE; CYPROHEPTADINE; DESIPRAMINE; DOPAMINE; FEMOXETINE; FENCLONINE; FLUOXETINE; HALOPERIDOL; INDALPINE; ISOPRENALINE; MAPROTILINE; MAZINDOL; METIROSINE; METITEPINE; NISOXETINE; NOMIFENSINE; NORADRENALIN; PHENOXYBENZAMINE; PHENYLEPHRINE; PIMOZIDE; PINDOLOL; PIRANDAMINE; QUIPAZINE; RESERPINE; SALBUTAMOL; SEROTONIN; TALSUPRAM; YOHIMBINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL MODEL; BRAIN; CENTRAL NERVOUS SYSTEM; DOPAMINERGIC SYSTEM; DRUG COMPARISON; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MODEL; RAT; SEROTONINERGIC SYSTEM; SWIMMING;

ANIMALS; BRAIN CHEMISTRY; CATECHOLAMINES; DOPAMINE; MALE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NOREPINEPHRINE; RATS; RECEPTORS, ADRENERGIC; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SEROTONIN; SWIMMING;

EID: 0018286649     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(79)90366-2     Document Type: Article

References (33)

1. On the central noradrenergic mechanism involved in haloperidol-induced catalepsy in the rat
2. Biogenic amine hypothesis in affective disorders
3. Blockade of presynaptic α-receptors and of amine uptake in the rat brain by the antidepressant mianserine
4. Neurochemical and pharmacological studies on a new 5-HT-uptake inhibitor, FG 49 63, with potential antidepressant properties
5. Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-metatyramine
6. Effect of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4-α-dimethyl-metatyramine
7. Effects of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro
8. Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine
9. The in vivo formation of p-chloro-β-phenylethylamine in young rats injected with p-chlorophenylalanine
10. Profil psychopharmacologique de l'isoprénaline et du salbutamol
11. Inhibition of serotonin uptake
12. Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum
13. Neurochemical characterization of a new potent and selective serotonin uptake inhibitor, Lu 10-171
14. Norepinephrine, epinephrine and the sympathomimetic amines
15. Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxy-indole metabolism
16. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain
17. p-Chlorophenyl-alanine: a specific depletor of brain serotonin
18. Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools
19. Effects of 4-(3-indolyl-alkyl) piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxytryptamine in rat brain synaptosomes, rat heart and human blood platelets
20. The effects of tandaminel, a new potential antidepressant agent on biogenic amine uptake mechanisms and related activities
21. Maprotiline, its position as an antidepressant in the light of recent neuropharmacological and neurobiochemical findings
22. Fefluramine: a review of its pharmacological properties and therapeutic efficacy in obesity
23. Behavioural despair in rats: a new model sensitive to antidepressant treatments
24. Behavioural despair in mice: a primary screening test for antidepressants
25. Behavioural despair in rats and mice: strain differences and the effects of imipramine
26. Depression: a new animal model sensitive to anti-depressant treatments
27. Choice of antidepressants
28. Biochemical and pharmacological studies of Ro 1-9569 (tetrabenazine), a non-indole tranquilising agent with reserpine-like effects
29. Antagonism by mianserin and classical α-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine
30. Preferential blockade of presynaptic α-adrenoceptors by yohimbine
31. Presynaptic receptor systems in catecholaminergic transmission
32. Antidepressant effect of salbutamol
33. d,l-N-methyl-3-(O-methyl phenoxy)-3-phenylpropylamine hydrochloride, Lilly 94939, a potent inhibitor for uptake into rat brain synaptosomes and heart